Mise à jour d'une déclaration précédente
No de la demande: 2009-1008
Numéro de référence du titulaire d'homologation: Prosar 1-17719327
Nom du titulaire (nom légal complet, aucune abbréviation): Syngenta Crop Protection Canada, Inc.
Adresse: 140 Research Lane, Research Park
Ville: Guelph
État: Ontario
Pays: Canada
Code postal /Zip: N1G4Z3
Incident chez l'humain
Pays: UNITED STATES
État: PENNSYLVANIA
Inconnu
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Non-Specific Paraquat Herbicide
Inconnu
Inconnu
Professionnel de la santé
Sexe: Femme
Âge: >19 <=64 yrs / >19 <=64 ans
Système
Unknown / Inconnu
Oui
Oui
Inconnu
Inconnu
Autre
Inconnu
Inconnu
Unknown / Inconnu
Unknown / Inconnu
1-17719327: A reporter (attending physician) called on 03/02/2009 to report the possible exposure of a female patient to an herbicide containing the active ingredient Paraquat. According to the reporter, the patient was in multi-system failure and the reporter was trying to rule out Paraquat exposure as the cause for her signs. The patient had tested positive for marijuana. The reporter thought that smoking sprayed marijuana may be a potential source of exposure. The patient also had marital trouble so there was some suspicion that she may have been intentionally poisoned. The reporter was unwilling to provide any further information due to patient privacy concerns and requested the Paraquat testing protocol. The reporter was provided Paraquat information (diagnosis, first aid, and hospital treatment) via fax. On follow up on 03/04, the patient¿s nurse reported that the Paraquat test results had not yet been received. At the time of follow up, the patient was in critical condition and on a ventilator. No further information was provided. After an unsuccessful follow up attempt on 03/06, contact was re-established on 03/07 with the patient¿s nurse. An arsenic test had come back positive in small amounts, possibly from ingestion of well water. The Paraquat results were still pending. The patient had been removed from the ventilator, but she was still hospitalized in the intensive care unit (ICU). Another follow up was performed on 03/09. The patient¿s nurse indicated that the patient had been removed from the ventilator on 03/05/2009. The cause of the signs remained unknown. The patient had been diagnosed with pancreatitis (elevated lipase and amylase levels). She also had elevated kidney values (serum creatinine and blood urea nitrogen). A thoracic CT scan had been performed on 03/09/2009 which revealed bibasilar infiltrates and interstitial pulmonary edema. The nurse indicated that the Paraquat test results were not expected until 03/12/2009. Another follow up to the patient¿s nurse on 03/12/2009 revealed that the patient was much improved. The patient was going to be transferred out of ICU to a medical-surgical patient area. Her white count was slightly elevated but all of the other lab work was within normal limits. An attempt at follow up on 03/16/2009 was unsuccessful. A follow up call was placed on 03/18/2009. The patient was still hospitalized and stable. No other information was provided.
Majeure
It is unknown whether the patient had been exposed to Paraquat. Potential routes of exposure included smoking marijuana that had been treated with the product, and intentional poisoning. The initial reporter (attending physician) was trying to rule out all possible causes for the patient's signs.